Matsunaga T
Section of Cellular Immunology, Institute of Immunological Science, Hokkaido University.
Hokkaido Igaku Zasshi. 1987 Sep;62(5):779-89.
It was recently demonstrated that MRL-lpr lymphoid cells transferred into lethally irradiated MRL- +mice unexpectedly failed to induce the early onset of lupus syndrome and massive lymphadenopathy of the donor, instead they caused a severe wasting syndrome resembling graft-vs-host (GvH) disease. The present studies were carried out to characterize the cellular events involved in the severe GvH-like reaction developed in C57BL/6 (B6) recipients of B6-lpr spleen cells, designated as [B6-lpr----B6] chimeras. [B6-lpr----B6] chimeras showed at 2 weeks post transplantation marked splenomegaly consisting predominantly of Lyt2+ T cells (approximately 70%), and subsequently developed acute and severe depletion in spleen cells causing spleen atrophy and fibrosis. Spleen cells from chimeras at 2 weeks posttransfer were not cytotoxic to both recipient and donor ConA blast target cells. In contrast, those cells (irradiated to 3000 rad) considerably suppressed ConA-induced proliferative responses of B6 spleen cells. These nonspecific suppressor cells expressed Thy1 and Lyt2 antigens, but lacked L3T4 and B220 antigens. Furthermore, elimination of Thy1+ or B220+ but neither L3T4+ nor Lyt2+ cells from B6-lpr spleen cells before transfer retarded the generation of nonspecific suppressor cells but did not abrogate the GvH-like disease. These results suggest that the GvH-like disease and lymphoid atrophy in [B6-lpr----B6] chimeras were mediated by Lyt2+ suppressor T cells, and that B220+ T cells played a crucial role in the induction of these suppressor cells. The cell transfer model reported here may be very useful in understanding the immunological function of B220+ T cells in vivo.
最近有研究表明,将MRL - lpr淋巴细胞移植到经致死剂量照射的MRL +小鼠体内,出乎意料的是,并未引发供体狼疮综合征的早期发作和大规模淋巴结病,反而导致了一种类似于移植物抗宿主(GvH)病的严重消瘦综合征。本研究旨在对C57BL/6(B6)受体接受B6 - lpr脾细胞(命名为[B6 - lpr----B6]嵌合体)后发生的严重GvH样反应所涉及的细胞事件进行表征。[B6 - lpr----B6]嵌合体在移植后2周出现明显的脾肿大,主要由Lyt2 + T细胞(约70%)组成,随后脾细胞出现急性严重耗竭,导致脾脏萎缩和纤维化。移植后2周嵌合体的脾细胞对受体和供体的刀豆蛋白A(ConA)刺激的靶细胞均无细胞毒性。相反,这些细胞(照射至3000拉德)显著抑制了B6脾细胞ConA诱导的增殖反应。这些非特异性抑制细胞表达Thy1和Lyt2抗原,但缺乏L3T4和B220抗原。此外,在移植前从B6 - lpr脾细胞中去除Thy1 +或B220 +细胞,但不包括L3T4 +或Lyt2 +细胞,会延迟非特异性抑制细胞的产生,但不会消除GvH样疾病。这些结果表明,[B6 - lpr----B6]嵌合体中的GvH样疾病和淋巴细胞萎缩是由Lyt2 +抑制性T细胞介导的,并且B220 + T细胞在这些抑制细胞的诱导中起关键作用。本文报道的细胞移植模型可能对理解B220 + T细胞在体内的免疫功能非常有用。